These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go? Pathak A; Ewen S; Fajadet J; Honton B; Mahfoud F; Marco J; Schlaich M; Schmieder R; Tsioufis K; Ukena C; Zeller T EuroIntervention; 2014 May; 10(1):21-3. PubMed ID: 24832632 [No Abstract] [Full Text] [Related]
25. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings. Esler M J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320 [TBL] [Abstract][Full Text] [Related]
26. Denervation (ablation) of nerve terminalis in renal arteries: early results of interventional treatment of arterial hypertension in Poland. Bartuś K; Sadowski J; Kapelak B; Zajdel W; Godlewski J; Bartuś S; Bochenek M; Bartuś M; Żmudka K; Sobotka PA Kardiol Pol; 2013; 71(2):152-8. PubMed ID: 23575708 [TBL] [Abstract][Full Text] [Related]
27. [Renal artery stenosis long time after renal denervation for resistant hypertension]. Denolle T; Heautot JF Ann Cardiol Angeiol (Paris); 2018 Jun; 67(3):204-207. PubMed ID: 29804655 [TBL] [Abstract][Full Text] [Related]
28. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system. Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940 [TBL] [Abstract][Full Text] [Related]
29. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial. Yerasi C; Baker NC; Jonnalagadda AK; Torguson R; Singh S; Vies J; Waksman R J Am Soc Hypertens; 2015 Dec; 9(12):959-65. PubMed ID: 26687550 [TBL] [Abstract][Full Text] [Related]
30. Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence. Hiremath S; Froeschl M; Ruzicka M Curr Opin Cardiol; 2014 Jul; 29(4):336-43. PubMed ID: 24859619 [TBL] [Abstract][Full Text] [Related]
31. Does the presence of accessory renal arteries affect the efficacy of renal denervation? Id D; Kaltenbach B; Bertog SC; Hornung M; Hofmann I; Vaskelyte L; Sievert H JACC Cardiovasc Interv; 2013 Oct; 6(10):1085-91. PubMed ID: 24156968 [TBL] [Abstract][Full Text] [Related]
32. First‑in‑man experience with renal denervation of multiple renal arteries in a patient with solitary kidney and resistant hypertension. Możeńska O; Rosiak M; Gziut A; Gil RJ; Kosior DA Pol Arch Intern Med; 2017 Jan; 127(1):60-62. PubMed ID: 28146462 [No Abstract] [Full Text] [Related]
33. Renal denervation in a patient with two renal accessory arteries: a case report. Bertoldi L; Latib A; Piraino D; Regazzoli D; Sticchi A; Pizzetti G; Camici PG; Colombo A Blood Press; 2013 Oct; 22(5):325-8. PubMed ID: 23547744 [TBL] [Abstract][Full Text] [Related]
35. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter. Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556 [TBL] [Abstract][Full Text] [Related]
36. Multimodality Intra-Arterial Imaging Assessment of the Vascular Trauma Induced by Balloon-Based and Nonballoon-Based Renal Denervation Systems. Karanasos A; Van Mieghem N; Bergmann MW; Hartman E; Ligthart J; van der Heide E; Heeger CH; Ouhlous M; Zijlstra F; Regar E; Daemen J Circ Cardiovasc Interv; 2015 Jul; 8(7):e002474. PubMed ID: 26156150 [TBL] [Abstract][Full Text] [Related]
37. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension. van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672 [TBL] [Abstract][Full Text] [Related]
38. Microdissection of the Human Renal Nervous System: Implications for Performing Renal Denervation Procedures. García-Touchard A; Maranillo E; Mompeo B; Sañudo JR Hypertension; 2020 Oct; 76(4):1240-1246. PubMed ID: 32829660 [TBL] [Abstract][Full Text] [Related]
39. Next generation renal denervation: chemical "perivascular" renal denervation with alcohol using a novel drug infusion catheter. Fischell TA; Fischell DR; Ghazarossian VE; Vega F; Ebner A Cardiovasc Revasc Med; 2015 Jun; 16(4):221-7. PubMed ID: 25979565 [TBL] [Abstract][Full Text] [Related]
40. Frequency of renal artery stenosis after renal denervation in patients with resistant arterial hypertension. Lambert T; Nahler A; Reiter C; Schwarz S; Gammer V; Blessberger H; Kammler J; Saleh K; Grund M; Steinwender C Am J Cardiol; 2015 Jun; 115(11):1545-8. PubMed ID: 25846764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]